Lv4
580 积分 2025-04-10 加入
Refining Risk Factors for Gastric Cancer in Patients With Lynch Syndrome to Optimize Surveillance Esophagogastroduodenoscopy
1小时前
已关闭
Hereditary diffuse gastric cancer in progress: Comparative lessons from Lynch syndrome
13小时前
待确认
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
2个月前
已完结
A New Initiative on Precision Medicine
4个月前
已完结
Structure–activity relationships of KRAS-G12D inhibitors for pancreatic cancer
5个月前
已完结
Recent advances in therapeutic targeting of the KRAS pathway in cancer
5个月前
已完结
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
5个月前
已完结
Oncogenic KRAS Drives Immune Suppression in Colorectal Cancer
6个月前
已完结
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials
6个月前
已完结
皖公网安备34019202002308
